Skip to content
Open access

Programmable Organic A2S-TT NPs for NIR-II/Photoacoustic Imaging-Enabled Precision Therapy

Sep 2026 · Pharmaceutics · Vol 18 · 0 citations · 33 references
Medicine

TL;DR

A2S-TT NPs achieved precise, efficient, safe, and controllable PDT through dual-mode imaging using NIR-II and PA, providing a novel strategy with clinical translation potential for the integrated diagnosis and treatment of TNBC.

Abstract

Background: Triple-negative breast cancer (TNBC) is a highly aggressive subtype of breast cancer characterized by significant treatment challenges and poor prognosis. Traditional therapies such as surgical resection, radiotherapy, and chemotherapy often suffer from limitations including insufficient therapeutic specificity, potential damage to normal tissues, and limited imaging capability. The integrated diag{Pareja, 2018 #13}nosis-treatment platform combines diagnostic and therapeutic functions, offering a novel approach for real-time tumor monitoring and precision therapy. Methods: Accordingly, this study designed and developed an integrated diagnostic and therapeutic platform called A2S-TT NPs, utilizing self-assembled nanoparticles incorporating organic conjugated molecules for precise photodynamic therapy (PDT) guided by dual modalities of Near-infrared II (NIR-II) fluorescence imaging and photoacoustic imaging (PA). Results: Under 808 nm laser excitation, A2S-TT NPs efficiently generated reactive oxygen species (ROS) at the tumor site, inducing mitochondrial membrane potential disruption and DNA damage to activate apoptosis. In vitro experiments demonstrated that A2S-TT NPs exhibited intense NIR-II fluorescence and photoacoustic signals, showcasing excellent dual-modal imaging potential. Moreover, it demonstrated minimal cytotoxicity in the absence of light exposure but significantly enhanced tumor cell killing under laser irradiation, demonstrating superior biosafety and photodynamic efficacy. In vivo studies further confirmed that A2S-TT NPs effectively accumulated at tumor sites, enabling visualization-based monitoring through its mediated NIR-II and PA dual-modal imaging. Additionally, A2S-TT NPs-mediated PDT exhibited remarkable tumor-suppressive effects while avoiding significant damage to normal tissues. Discussion: This study constructs a novel PA/NIR-II dual-modal imaging-guided PDT platform based on donor–acceptor conjugated polymer A2S-TT NPs for integrated TNBC theranostics. PA provides high-resolution deep-tissue imaging, while NIR-II fluorescence offers high sensitivity and deep penetration; their complementary strengths support precise tumor localization and real-time therapeutic monitoring. Under dual-modal guidance, A2S-TT NPs enrich in tumors and generate abundant ROS upon 808 nm laser irradiation to boost PDT efficacy. In vitro and in vivo biosafety tests confirm its favorable biocompatibility with minimal systemic toxicity at therapeutic doses. Conclusions: In conclusion, A2S-TT NPs achieved precise, efficient, safe, and controllable PDT through dual-mode imaging using NIR-II and PA, providing a novel strategy with clinical translation potential for the integrated diagnosis and treatment of TNBC.

Read PDF

Similar papers

Sep 2026

TME-Activated Nanofactory Orchestrate NIR-II Fluorescence/Photoacoustic Imaging-Guided Synergistic Chemodynamic/Photothermal Antitumor Therapy.

A novel responsive multifunctional Ag2S/MnO2@SiO2@SiO2 (AMS) nanofactory was constructed for NIR-II fluorescence/photoacoustic (NIR-II FL/PA) imaging-guided synergistic chemodynamic/photothermal therapy (CDT/PTT) of TNBC.

Rong Dai, Chun-Mei Jiang, Hao-Yu Liu et al. · 0 citations
Sep 2026

Near-Infrared Laser-Responsive Nanoplatform for Photodynamic/Photothermal/Chemodynamic Combined Therapy

Surgical resection remains a conventional clinical strategy for melanoma treatment, yet it still suffers from considerable clinical bottlenecks, including difficult surgical operations and unintended damage to adjacent normal tissues. Herein, a multifunctional nanoplatform, CeO2-ICG@PDA (CeICP NPs), was constructed....

Han Hu, Shi-Jie Yao, Hao Jia et al. · 0 citations
Review Oct 2026

Engineering upconversion nanoparticles for synergistic photodynamic, photothermal and chemotherapy.

Cancer remains a significant threat to human health, and photodynamic therapy (PDT) is recognized as a clinically effective therapeutic strategy for tumor treatment owing to its high spatiotemporal control and minimal invasiveness. However, its application is constrained by critical limitations of conventional photosen...

Chen-Kun Gao, Bing-Rui Li, Hang Shangguan et al. · 0 citations
Review Open access Sep 2026

Advances in gold and silver nanoplatforms for photon therapies in breast cancer

Breast cancer (BC) remains a major global health challenge due to tumor heterogeneity, therapeutic resistance, recurrence, and treatment-associated toxicity. Photon-based therapies, including photodynamic therapy (PDT), photothermal therapy (PTT), and radiotherapy (RT), offer spatially controlled approaches for cance...

Ana L. F. Santos, C. A. Salvego, C. R. Silva et al. · 0 citations
Open access Aug 2026

A Dual GSH/ROS-Functional NIR Fluorescent Platform for Synergistic Photodynamic Therapy and Radiosensitization in Nasopharyngeal Carcinoma.

A theranostic platform HSF, featuring integrated tumor-specific near-infrared fluorescence imaging and photodynamic ROS generation for real time monitoring and targeted radiotherapy of solid malignancies for NPC, offering a transformative approach for real time visualization-guided NPC therapy.

Fan Zheng, Yan Mo, Jin Zhou et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.